Concurrent capecitabine and upper abdominal radiation therapy is well tolerated

We retrospectively evaluated acute toxicity in 88 patients that were treated with capecitabine and concurrent radiotherapy to the upper abdomen. These patients included 28 (32%) with pancreatic adenocarcinoma, 18 (20%) with cholangiocarcinoma, 11 (13%) with ampullary carcinoma, 11 (13%) with other p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Das, Prajnan, Wolff, Robert A, Abbruzzese, James L, Varadhachary, Gauri R, Evans, Douglas B, Vauthey, Jean Nicolas, Baschnagel, Andrew, Delclos, Marc E, Krishnan, Sunil, Janjan, Nora A, Crane, Christopher H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2006
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1634749/
https://ncbi.nlm.nih.gov/pubmed/17062148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-1-41
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak